Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Versant Ventures
San Francisco, California, United Statesversantventures.com ↗
- Ownership
- Private
- Employees
- ~55
- Development stage
- Other
01
Overview
Versant Ventures does not develop drugs itself but has enabled over 100 successful IPOs or acquisitions of its portfolio companies since 1999. Its investments span early-stage discovery through late clinical development across biotech sectors globally.
- Therapeutic areas
- CardiovascularMetabolic DisordersImmunologyEndocrinologyOncologyNeurology
- Modalities
- Small moleculeGene therapyMonoclonal antibodymRNA-based drugsCell therapy
- Industry
- Investors
02
Partnerships
Extensive academic partnerships (>30 institutions globally)Co-investments with major VCs/pharma including Bayer and Vertex via portfolio companies like CRISPR Therapeutics
Beyond the preview
Go deeper on Versant Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Versant Ventures.